The Oncology Small Molecule Drugs Market is poised for significant expansion, with a projected compound annual growth rate (CAGR) of 5.6% from 2025 to 2031, according to the latest report by The Insight Partners. The surge in market growth is primarily attributed to technological advancements in drug discovery, increasing adoption of personalized medicine, and the rising global incidence of...